Source: Annual Congress 2005 - Mechanisms of inflammatory reactions in asthma, COPD and models of allergic airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. L. Simpson, J. Douwes, T. V. Grissell, P. G. Gibson (Newcastle, Australia; Wellington, New Zealand). Asthma with fixed airways obstruction is characterised by increased airway endotoxin, IL-8 and OSM. Eur Respir J 2005; 26: Suppl. 49, 3750

Member's Comments

No comment yet.

Related content which might interest you: Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13 Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Serum IL-12p70 and IL-12p40 levels in severe asthma patients with fixed airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 234s Year: 2006 Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13 Source: Eur Respir J 2008; 32: 571-578 Year: 2008 The possible role of IL-5 and IFN-γ in the forming of cold airway hyperresponsiveness in patients with bronchial asthma Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 The airway microbiota is significantly altered in asthma patients with airway hyperresponsiveness to mannitol Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Increased airway closure is a determinant of airway hyperresponsiveness Source: Eur Respir J 2008; 32: 1563-1569 Year: 2008 Over-expression of Th17-related cytokines in bronchial and nasal submucosa in severe asthma Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006 Outgrown asthma does not mean no airways inflammation Source: Eur Respir J 2002; 19: 284-287 Year: 2002 Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001 Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Interleukin-17 in induced sputum correlates with airway hyperresponsiveness to methacholine Source: Eur Respir J 2001; 18: Suppl. 33, 193s Year: 2001 IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011